MedTrace Logo

Non Syndromic Congenital Heart Defect and Array-CGH in Prenatal Diagnosis

NCT02333097 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2019-01-28

No results posted yet for this study

Summary

Comparative genomic hybridization (CGH)-based microarrays are now often used during pregnancy in case of fetal polymalformation in order to assess significant genomic alterations. However, it is not clear whether array-CGH provide a diagnostic utility in case of isolated congenital heart defect.

This is the first prospective study aiming at defining the right chromosomal screening when a fetal isolated congenital heart defect is identified by ultrasound.

Conditions

  • Non Syndromic Congenital Heart

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Laurent Pasquier, PH · Rennes University Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-08-31
Completion
2018-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02333097 on ClinicalTrials.gov